New price cuts on innovator drugs in Spain could have domino effect across Europe
This article was originally published in Scrip
Executive Summary
The pharmaceutical industry in Spain has condemned new price cuts on patented medicines announced yesterday by president, José Luis Rodríguez Zapatero. Industry has warned that the reductions could have a knock-on effect on prices elsewhere in Europe thanks to reference pricing.